BPC-157 vs TB-500: Which Recovery Peptide Actually Works?
Mechanism, published data, dosing, timing, stacking, and side-effect profile compared for the two most common healing peptides.
BPC-157 and TB-500 (thymosin beta-4 fragment) are the two peptides most people reach for when a tendon, ligament, or gut lining is not healing. They work through different mechanisms and — despite what most forum posts claim — the human evidence for both is thin. Here is the honest comparison.
The mechanisms differ
BPC-157 is a 15-amino-acid fragment derived from a protein in gastric juice. In rodent studies it up-regulates VEGFR2, promotes angiogenesis, and appears to accelerate tendon-to-bone healing (Chang et al., 2011). It works best on tissue that is actively injured or under repair.
TB-500 is the synthetic fragment of thymosin beta-4 that contains the actin-binding domain. It promotes cell migration and appears to help wound closure and epithelial repair in animal models (Goldstein et al., 2012). It is more of a 'send repair cells to the site' peptide than a 'grow blood vessels' one.
Head-to-head
| Attribute | BPC-157 | TB-500 |
|---|---|---|
| Best for | Tendon, ligament, GI lining | Muscle tears, systemic recovery |
| Onset | 3–7 days | 1–3 weeks |
| Typical dose | 250–500 mcg/day | 2–5 mg/week |
| Route | SubQ near injury, or IM | SubQ, systemic |
| Human trials | Very limited (mostly oral GI) | Almost none |
| Half-life | ~4 hours | ~2–3 days |
| Cost/month | $25–$50 | $40–$80 |
When to pick which
- Localized injury (tennis elbow, Achilles, plantar fascia): BPC-157, injected subcutaneously as close to the site as safely possible.
- Systemic muscle recovery or a hard training block: TB-500, once weekly.
- GI issues, ulcers, IBD flares: BPC-157 oral or subQ. This is the one area with the most consistent (still-animal) data.
- Post-surgical recovery: many users stack both at reduced doses. Evidence for the stack is anecdotal only.
What the evidence does not support
You will see claims that BPC-157 heals torn ligaments in humans, restores cartilage, or reverses tendinopathy on MRI. None of that has been demonstrated in a controlled human trial. The rodent data is genuinely interesting; the extrapolation to humans is a bet, not a fact.
Reconstitution quick reference
Both come as lyophilized powder. Add bacteriostatic water, do not shake, swirl gently. For a 5 mg BPC-157 vial reconstituted with 2 ml BAC water, 10 units on a U-100 insulin syringe = 250 mcg. Full math is in the calculator.
References
- Chang CH et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth. J Appl Physiol 2011.
- Goldstein AL et al. Thymosin β4: a multi-functional regenerative peptide. Expert Opin Biol Ther 2012.
- Sikiric P et al. Stable gastric pentadecapeptide BPC 157 review. Curr Pharm Des 2018.
- FDA 503A Bulk Substances Under Evaluation.